Gene expression profiling of drug metabolism and toxicology markers using a low-density DNA microarray

被引:58
作者
de Longueville, F
Surry, D
Meneses-Lorente, G
Bertholet, V
Talbot, V
Evrard, S
Chandelier, N
Pike, A
Worboys, P
Rasson, JP
Le Bourdellès, B
Remacle, J
机构
[1] Univ Namur, Lab Biochem & Cellular Biol, B-5000 Namur, Belgium
[2] Merck Sharp & Dohme Ltd, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England
[3] Univ Namur, Dept Math, Stat Unit, Namur, Belgium
[4] Vernalis Res Ltd, Wokingham RG41 5UA, England
关键词
low-density microarray; quantitative assay; toxicogenomics; drug metabolism; CYP2B and CYP3A inducer; rat liver;
D O I
10.1016/S0006-2952(02)01055-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
DNA microarrays are useful tools to study changes of gene expression in response to a treatment with drugs. Here, we describe the optimization of conditions for the cDNA synthesis and hybridization protocols to be used for a low-density DNA microarray called 'Rat HepatoChips.' This DNA microarray with 59 carefully selected genes could be used to study changes in gene expression levels due to a treatment with xenobiotic. These 59 genes (including 8 housekeeping genes) have been selected among potential toxic markers involved in basic cellular processes and drug metabolism related genes. Using the optimized conditions, the results were shown to be reproducible, with 6% variation between the duplicated spots and 10% between arrays. Conditions were optimized to allow quantification with a dynamic range of four log units. In order to demonstrate the major advantage of these tool for studying gene expression, samples of control rat liver were compared with those of animals dosed with phenobarbital (PB) or pregnenolone-16alpha-carbonitrile (PCN), two compounds well known to induce cytochrome P450 isoforms of 2B and 3A subfamilies, respectively. This microarray has shown that other genes apart from the corresponding CYP P450 genes have been changed due to PB and PCN treatment. Apoptosis-related genes have shown to be changed due to PB and PCN treatment, which confirms results from previous work. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:137 / 149
页数:13
相关论文
共 45 条
[1]  
Alberts B., 1994, MOL BIOL CELL
[2]   The retinoblastoma protein pathway and the restriction point [J].
Bartek, J ;
Bartkova, J ;
Lukas, J .
CURRENT OPINION IN CELL BIOLOGY, 1996, 8 (06) :805-814
[3]  
Chen Y, 1997, J Biomed Opt, V2, P364, DOI 10.1117/12.281504
[4]   Role of transforming growth factor-β signaling in cancer [J].
de Caestecker, MP ;
Piek, E ;
Roberts, AB .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (17) :1388-1402
[5]  
DeRisi J, 1996, NAT GENET, V14, P457
[6]   ANALYSIS OF GENE-EXPRESSION IN SINGLE LIVE NEURONS [J].
EBERWINE, J ;
YEH, H ;
MIYASHIRO, K ;
CAO, YX ;
NAIR, S ;
FINNELL, R ;
ZETTEL, M ;
COLEMAN, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (07) :3010-3014
[7]  
Eickhoff B, 1999, Nucleic Acids Res, V27, pe33, DOI 10.1093/nar/27.22.e33
[8]   Quantitative assay for group M (subtype A-H) and group OHIV-1 RNA detection in plasma [J].
Ernest, I ;
Alexandre, I ;
Zammatteo, N ;
Herman, M ;
Houbion, A ;
De Lenner, F ;
Fransen, K ;
van der Groen, G ;
Remacle, J .
JOURNAL OF VIROLOGICAL METHODS, 2001, 93 (1-2) :1-14
[9]   Transforming growth factor-β1 induces apoptosis in rat FaO hepatoma cells via cytochrome c release and oligomerization of Apaf-1 to form a ∼700-kd apoptosome caspase-processing complex [J].
Freathy, C ;
Brown, DG ;
Roberts, RA ;
Cain, K .
HEPATOLOGY, 2000, 32 (04) :750-760
[10]  
Frueh FW, 1997, MOL PHARMACOL, V51, P363